2012
The intensity of internalization and cytotoxicity of superparamagnetic iron oxide nanoparticles with different surface modifications in human tumor and diploid lung cells |
Authors: M. MESAROSOVA, F. CIAMPOR, V. ZAVISOVA, M. KONERACKA, M. URSINYOVA, K. KOZICS, N. TOMASOVICOVA, A. HASHIM, I. VAVRA, Z. KRIZANOVA, Z. HUSEKOVA, M. KUBOVCIKOVA, P. KOPCANSKY, M. TIMKO, A. GABELOVA |
Neoplasma Vol.59, No.5, p.584-597, 2012 |
doi:10.4149/neo_2012_075 |
Price: free access |
[View Abstract]
|
|
|
|
The relationship of multifocality and tumor burden with various tumor characteristics and survival in early breast cancer |
Authors: G. KELEMEN, V. FARKAS, J. DEBRAH, K. ORMANDI, A. VOROS, L. KAIZER, Z. VARGA, G. LAZAR, Z. KAHAN |
Neoplasma Vol.59, No.5, p.566-573, 2012 |
doi:10.4149/neo_2012_073 |
Price: free access |
[View Abstract]
|
|
|
|
Knockdown of RhoGDIα induces apoptosis and increases lung cancer cell chemosensitivity to paclitaxel |
Authors: F. RONG, W. LI, K. CHEN, D. M. LI, W. M. DUAN, Y. Z. FENG, F. LI, X. W. ZHOU, S. J. FAN, Y. LIU, M. TAO |
Neoplasma Vol.59, No.5, p.541-550, 2012 |
doi:10.4149/neo_2012_070 |
Price: free access |
[View Abstract]
|
|
|
|
PET/CT significance for planning radiotherapy of head and neck cancer |
Authors: I. KOLAROVA, J. VANASEK, V. KANDRNAL, K. ODRAZKA, L. DUSEK, V. CHROBOK, O. BELOHLAVEK, M. DOLEZEL, L. PETRUZELKA, R. MICHALEK, J. JARKOVSKY |
Neoplasma Vol.59, No.5, p.536-540, 2012 |
doi:10.4149/neo_2012_069 |
Price: free access |
[View Abstract]
|
|
|
|
Immunohistochemical and histomorphological analysis of rat mammary tumors after simvastatin treatment |
Authors: P. KUBATKA, K. KAJO, K. ZIHLAVNIKOVA, K. ADAMICOVA, D. VYBOHOVA, M. PEC, V. NOSAL, N. STOLLAROVA, B. BOJKOVA, M. KASSAYOVA, P. ORENDAS |
Neoplasma Vol.59, No.5, p.516-523, 2012 |
doi:10.4149/neo_2012_066 |
Price: free access |
[View Abstract]
|
|
|
|
Epidermal growth factor receptor (EGFR) expression and mutations
in the EGFR signaling pathway in correlation with anti-EGFR therapy
in head and neck squamous cell carcinomas |
Authors: P. SMILEK, J. NEUWIRTHOVA, J. JARKOVSKY, L. DUSEK, J. ROTTENBERG, R. KOSTRICA, J. SROVNAL, M. HAJDUCH, J. DRABEK, J. KLOZAR |
Neoplasma Vol.59, No.5, p.508-515, 2012 |
doi:10.4149/neo_2012_065 |
Price: free access |
[View Abstract]
|
|
|
|
Biomarkers in the Lung Cancer Diagnosis: A Clinical Perspective |
Authors: X. LI, T. ASMITANANDA, L. GAO, D. GAI, Z. SONG, Y. ZHANG, H. REN, T. YANG, T. CHEN, M. CHEN |
Neoplasma Vol.59, No.5, p.500-507, 2012 |
doi:10.4149/neo_2012_064 |
Price: free access |
[View Abstract]
|
|
|
|
Perioperative interstitial CT-based brachytherapy boost in breast cancer patients with breast conservation after neoadjuvant chemotherapy |
Authors: M. DOLEZEL, K. STASTNY, K. ODRAZKA, J. VANASEK, T. KOHLOVA, D. DVORAKOVA, I. KOLAROVA, T. KROULIK, L. JALCOVA |
Neoplasma Vol.59, No.5, p.494-499, 2012 |
doi:10.4149/neo_2012_063 |
Price: free access |
[View Abstract]
|
|
|
|
SKLB1002, a novel inhibitor of VEGF receptor 2 signaling, induces vascular normalization to improve systemically administered chemotherapy efficacy |
Authors: G. Shen, Y. Li, T. Du, G. Shi, L. Dai, X. Chen, R. Zheng, W. Li, X. Su, S. Zhang, Y. Wei, S. Yang, H. Deng |
Neoplasma Vol.59, No.5, p.486-493, 2012 |
doi:10.4149/neo_2012_062 |
Price: free access |
[View Abstract]
|
|
|
|
The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma |
Authors: S. YIGIT, L. DEMIR, M. O. TARHAN, F. K. CABUK, H. ELLIDOKUZ, C. ERTEN, I. SOMALI, A. DIRICAN, F. CAKALAGAOGLU |
Neoplasma Vol.59, No.5, p.475-485, 2012 |
doi:10.4149/neo_2012_061 |
Price: free access |
[View Abstract]
|
|
|
|
Melatonin enhanced bexarotene efficacy in experimental mammary carcinogenesis |
Authors: P. ORENDAS, P. KUBATKA, K. KAJO, N. STOLLAROVA, M. KASSAYOVA, B. BOJKOVA, M. PEC, V. NOSAL, T. KISKOVA, K. ZIHLAVNIKOVA, R. KARSNAKOVA |
Neoplasma Vol.59, No.4, p.469-474, 2012 |
doi:10.4149/neo_2012_060 |
Price: free access |
[View Abstract]
|
|
|
|
Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma – Phase II study results |
Authors: L. ZAHRADOVA, K. MOLLOVA, D. OCADLIKOVA, L. KOVAROVA, Z. ADAM, M. KREJCI, L. POUR, A. KRIVANOVA, V. SANDECKA, R. HAJEK |
Neoplasma Vol.59, No.4, p.440-449, 2012 |
doi:10.4149/neo_2012_057 |
Price: free access |
[View Abstract]
|
|
|
|
Results 21 - 40 of 95
Recently Viewed Products
-
Neoplasma Vol.54, p.311-320, 2007 (Category:
2007)
-
General Physiology and Biophysics Vol.29, No.3, p.266–274, 2010 (Category:
2010)
-
General Physiology and Biophysics Vol.29, No.3, p.309-313, 2010 (Category:
2010)
-
Bratislava Medical Journal Vol.122, No.12, p.839–845,2021 (Category:
2021)
-
Neoplasma Vol.63, No.5, p.705-716,2016 (Category:
2016)
-
Kovove Materialy-Metallic Materials Vol. 57 (2019), no. 5, pp.307–316 (Category:
2019)